Immunomedics

TRODELVY

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / TRODELVY – J9317

Manufacturer:

Immunomedics

Name:

TRODELVY

HCPCS Code Descriptor:

Injection, sacituzumab govitecan-hziy, 2.5 mg

Category:

J Code

HCPCS:

J9317

NDC(s):

55135-0132-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

TRODELVY is an Oncology drug manufactured by Immunomedics and administered via the Intravenous route of administration. The J Code: J9317 is aligned to the drug TRODELVY.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/21

HCPCS Effective Date:

1/1/21

HCPCS Short Description:

Sacituzumab govitecan-hziy

Billing and Coding Guide:

https://www.trodelvyhcp.com/-/media/project/trodelvy/trodelvyhcp/hcp/resource-pdf/reimbursement-billing-coding-guide-2021-trot00107.pdf

Patient Assistance:

https://www.trodelvy.com/

TRODELVY - J9317